How to Achieve FDA QSR Compliance: Best Practices & Regulatory Strategy

Short Description

FDA-aligned best practices for achieving and maintaining FDA QSR compliance for Medical Device manufacturers are stringent but necessary. Knowing the key regulatory expectations across the device lifecycle and having practical strategies in place to support inspection readiness and risk-based quality management, enables long-term regulatory compliance.

Quality System Regulation Amendments Final Rule were issued by the FDA to amend the CGMP requirements of 21 CFR part 820 to harmonize the regulations. The main aim of the QSR is to harmonize the ISO 13485:2016 Medical Devices – Quality management systems – Requirements for regulatory purposes. The stated rule came into effect from 2 February 2026 and is now known as Quality Management System Regulation (QMSR).

How to Achieve FDA QSR Compliance: Best Practices & Regulatory Strategy

Achieving and maintaining Food and Drug Administration (FDA) Quality System Regulation (QSR) compliance is essential for any Medical Device manufacturers that market devices in the United States. The QSR sets stringent requirements for the design, manufacture, packaging, labelling, storage, installation, and servicing of finished devices. The FDA inspects manufacturers for these requirements using structured inspection techniques. QSR consulting services (USA) provided by CliniExperts can help meet regulatory expectations without delay.

Meeting Medical Device quality system regulation requirements not only protects patients but also  reduces regulatory risk. But success requires a practical quality strategy, disciplined processes, and inspection-ready records. In this article, we outline best practices for achieving and sustaining QSR compliance for FDA, examine key expectations across device lifecycle, and discuss strategic approaches to prepare for FDA inspections having evolving quality system requirements.

1. Start With A Clear, Documented QMS

The QSR expects defined responsibilities, procedures, processes, and resources that ensure product quality is maintained throughout the product lifecycle. Your QMS should map to the core QSR subsystems, which include design controls, production and process controls, material controls, corrective and preventive actions (CAPA), equipment and facility controls, records, documents and change controls.¹

What you can do:

• Produce a single high-level Quality Manual that references detailed procedures and forms.
• Maintain a controlled document system with revision history and distribution lists (21 CFR 820.40).
• Assign an accountable management representative for quality.

Following requirements are mandatory for medical device companies:

• Quality Policy – Quality policy and objective are mandatory to maintain product quality. The policy must be understood, implemented and maintained throughout the organization.
• Organization – This includes establishing responsibility and authority for all persons who manage, perform, and assess work affecting quality, and the provision of resources to meet the requirements of the FDA QSR.
• Management Review – The reviews must ensure that the quality system meets the requirements of FDA QSR on an ongoing basis.
• Quality Planning – A quality plan must be produced by each manufacturer which defines the quality practices, resources and activities that must be conducted to satisfy the requirements for quality set out in the FDA QSR.
• Quality System Procedures – Each manufacturer must establish and maintain a set of procedures and instructions for implementing the quality system throughout the organization.

2. Embed Design Controls Early and Visibly

Design controls are a cornerstone of the QSR. They require planning, user needs, design inputs/outputs, design verification and validation, design reviews, and design transfer.²  You should integrate design controls from concept through transfer to manufacturing and not at the end of development. 

What you can do:

• Maintain traceability (from user needs, design inputs, verification/validation to risk controls).
• Document design reviews with multidisciplinary attendance and action items.
• Verify test methods and acceptance criteria before performing verification/validation.

3. Make CAPA your Continuous Improvement Engine

The CAPA subsystem is critical. It’s how you identify, investigate, and eliminate causes of nonconformities and potential problems. The FDA emphasises that CAPA activities must be documented, risk-based, and commensurate with the issue’s impact on safety and effectiveness.

What you can do:

• Define clear triggers for CAPA (complaints, trends, audit findings, nonconformances).
• Use root-cause analysis techniques and document evidence.
• Track effectiveness checks with objective measures and timelines (close CAPAs only when verification demonstrates effectiveness).

4. Prepare for FDA Inspections Using QSIT Principles

The FDA inspects QMSs using structured methods (e.g – Quality System Inspection Technique, QSIT). So, you should familiarise your teams with the inspection flow, such as records review, subsystem sampling, and evidence trails from complaint to CAPA and from design inputs to verification.

What you can do:

• Keep master records and device history records organised and accessible.
• Prepare a concise binder or electronic index mapping each QSR clause to your procedures and records.
• Train employees on how to respond to investigator questions and on the location of required records.

5. Risk-Based Thinking and Harmonisation With International Standards

The FDA has emphasised alignment with international QMS standards (ISO 13485) to reduce duplication and harmonise expectations. Thus, you should adopt risk-based approaches across your QMS, such as prioritising activities, resources, and documentation based on patient safety impact. You may use ISO-aligned practices where appropriate but ensure any differences with 21 CFR 820 are addressed explicitly in your procedures.

What you can do:

• Incorporate risk assessments into design, supplier selection, process validation, and CAPA.
• Maintain a gap-analysis document showing how ISO 13485 practices map to the QSR requirements.

6. Control Suppliers and Incoming Materials

Supplier controls (purchase controls, verification of purchased product) are regulated under the QSR. ¹ You should maintain supplier qualification records, incoming inspection plans, and agreements specifying quality requirements.Additionally, treat supplier issues as potential CAPA triggers and include suppliers in risk assessments that could affect device performance.

What you can do:

• Use a tiered supplier classification (from critical, monitored, to low risk).
• Require certificates of conformance and sample-based verification for critical components.
• Include supplier audit plans and performance metrics.

7. Maintain Strong Complaint Handling And Post market Surveillance

Complaint files feed several QSR subsystems. They inform CAPA, Medical Device Reporting (MDR) (where applicable), and risk management.5 

What you can do:

• Ensure that complaint intake, evaluation, trend analysis, and investigation procedures are robust and documented.
• Link complaints to CAPA actions and monitor trends quantitatively.

8. Leadership Commitment, Training, and Culture

Regulatory compliance is organisational, not just documentation. Senior management must be visibly committed (management review, resource allocation, quality objectives), and quality must be part of employee performance and training. 

What you can do:

• Train staff on standard operating procedures (SOPs), data integrity, and how their roles support patient safety and compliance.²

Regulatory Strategy and Practical Roadmap

A structured regulatory strategy, as discussed in Table 1 below, is essential to translate FDA QSR requirements into effective, inspection-ready quality system practices.

FDA: Food and Drug Administration; QMS: Quality Management System; CAPA: Corrective and Preventive Action

Note: Many Medical Device manufacturers rely on QSR consulting services USA to strengthen their quality management systems and prepare for FDA inspections.

Conclusion

Achieving and sustaining FDA QSR compliance requires more than just documented procedures. It demands a well-implemented, risk-based quality management that is integrated with the Medical Device quality system regulation. Thus, by embedding design controls early, maintaining effective CAPA and supplier controls, ensuring robust complaint handling, and preparing teams for FDA inspections using QSIT principles, manufacturers can reduce regulatory risk and support consistent product quality. Manufacturers may use QSR consulting services (USA & other countries) of regulatory service providers like Cliniexperts for the same. 

Further, strong leadership commitment, ongoing training, and continuous monitoring are essential to maintaining an inspection-ready state and adapting to evolving FDA quality system expectations.

References 

1. “Quality System Regulation Overview.” n.d. Accessed February 9, 2026. https://www.fda.gov/files/drugs/published/Overview-of-Quality-System-Regulation.pdf
2. “Design Controls.” n.d. Accessed February 9, 2026. https://www.fda.gov/media/116762/download.
3. “Guide-to-Inspections-of-Quality-Systems.Pdf.” n.d. Accessed February 9, 2026. https://www.fda.gov/files/Guide-to-Inspections-of-Quality-Systems.pdf.
4. “Quality Management System Regulation – Frequently Asked Questions | FDA.” Accessed February 9, 2026. https://www.fda.gov/medical-devices/quality-management-system-regulation-qmsr/quality-management-system-regulation-frequently-asked-questions.
5. “FDA Medical Device Inspections.” n.d. Accessed February 9, 2026. https://www.fda.gov/media/94076/download.